Estimated antiretroviral therapy coverage among people living with HIV in Algeria
Algeria: Estimated antiretroviral therapy coverage among people living with HIV was 80.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Algeria, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Algeria recorded 80.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025.
That represents a change of up 3.9% on the previous year and up 40.4% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Algeria peaked at 84.0% in 2021 and was at its lowest, 7.0%, in 2000.
Algeria ranks 54th of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Algeria, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 7.0% | — |
| 2001 | 8.0% | +14.3% |
| 2002 | 8.0% | +0.0% |
| 2003 | 9.0% | +12.5% |
| 2004 | 10.0% | +11.1% |
| 2005 | 11.0% | +10.0% |
| 2006 | 14.0% | +27.3% |
| 2007 | 14.0% | +0.0% |
| 2008 | 14.0% | +0.0% |
| 2009 | 17.0% | +21.4% |
| 2010 | 22.0% | +29.4% |
| 2011 | 25.0% | +13.6% |
| 2012 | 29.0% | +16.0% |
| 2013 | 38.0% | +31.0% |
| 2014 | 47.0% | +23.7% |
| 2015 | 57.0% | +21.3% |
| 2016 | 66.0% | +15.8% |
| 2017 | 72.0% | +9.1% |
| 2018 | 78.0% | +8.3% |
| 2019 | 81.0% | +3.8% |
| 2020 | 82.0% | +1.2% |
| 2021 | 84.0% | +2.4% |
| 2022 | 78.0% | -7.1% |
| 2023 | 80.0% | +2.6% |
| 2024 | 77.0% | -3.8% |
| 2025 | 80.0% | +3.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 11.2% | 7.0% | 17.0% | 10 |
| 2010s | 51.5% | 22.0% | 81.0% | 10 |
| 2020s | 80.2% | 77.0% | 84.0% | 6 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0516 units per person (2025)
- Population ages 05-09, male, annual growth rate -0.5109 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0537 units per person (2025)
- Population ages 10-14, female, annual growth rate 3.37 % change on previous year (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Algeria?
- Estimated antiretroviral therapy coverage among people living with hiv in Algeria was 80.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Algeria?
- The highest recorded value was 84.0% in 2021.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Algeria?
- The lowest recorded value was 7.0% in 2000.
- How does Algeria rank for estimated antiretroviral therapy coverage among people living with hiv?
- Algeria ranks 54th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Algeria?
- Over the last ten years it is up 40.4%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).